Company intelligence / Profile preview

AarogyaAI Innovations

Bengaluru, Karnataka, India

Ownership: Private
Employees: ~24
Development stage: Other

Overview

AarogyaAI provides AI- and genomics-based diagnostics that rapidly predict drug resistance and drug susceptibility for tuberculosis and other pathogens from genomic sequence data, enabling clinicians to select effective therapies within 24–48 hours rather than weeks; this is a diagnostic performance story, not a therapeutic clinical trial program.

Therapeutic areas: Infectious Diseases
Industry: Molecular Diagnostics

Partnerships

Illumina Accelerator (Illumina Inc.) – genomics startup accelerator supportAWS (Amazon Web Services) – cloud, AI/ML infrastructure and co‑commercialization support

Beyond the preview

Go deeper on AarogyaAI Innovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AarogyaAI Innovations.

Explore the full profile